11-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1153 17 887 93 1132 174 1059
ERLYTX 75 0 0 4 49 8 49
GI 169 1 52 14 170 23 140
GU 381 4 209 46 560 82 499
LEUK 167 4 209 15 183 29 177
LUNG 206 4 209 13 158 37 225
LYMPH 435 9 470 37 450 71 432
MELAN 7 0 0 0 0 2 12
MMYEL 108 3 157 6 73 17 103
MULT 51 0 0 1 12 5 30
OTHER 49 0 0 2 24 3 18
Total 2801 42 2193 231 2811 451 2744

11-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 203 5 261 20 244 37 225
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 1 6
GU 8 0 0 2 24 3 18
LEUK 611 6 313 53 645 104 633
LUNG 364 4 209 24 292 52 317
OTHER 15 2 104 5 61 7 43
PEOLC 78 0 0 0 0 4 24
PREV 230 3 157 10 122 21 128
SXQOL 662 9 470 54 657 124 755
Total 2174 29 1514 168 2045 353 2149

11-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1153 17 887 93 1132 174 1059
CCD 203 5 261 20 244 37 225
ERLYTX 77 0 0 4 49 8 49
GI 170 1 52 14 170 24 146
GU 389 4 209 48 584 85 517
LEUK 778 10 522 68 828 133 810
LUNG 570 8 417 37 450 89 542
LYMPH 435 9 470 37 450 71 432
MELAN 7 0 0 0 0 2 12
MMYEL 108 3 157 6 73 17 103
MULT 51 0 0 1 12 5 30
OTHER 64 2 104 7 85 10 61
PEOLC 78 0 0 0 0 4 24
PREV 230 3 157 10 122 21 128
SXQOL 662 9 470 54 657 124 755
Total 4975 71 3706 399 4856 804 4893

11-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 706 10 522 48 584 92 560
ERLYTX 53 0 0 2 24 6 37
GI 128 0 0 12 146 20 122
GU 287 2 104 30 365 57 347
LEUK 101 1 52 7 85 16 97
LUNG 130 3 157 10 122 27 164
LYMPH 285 7 365 25 304 47 286
MELAN 7 0 0 0 0 2 12
MMYEL 60 0 0 1 12 10 61
MULT 19 0 0 0 0 2 12
OTHER 49 0 0 2 24 3 18
Total 1825 23 1200 137 1666 282 1716

11-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 150 5 261 15 183 24 146
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 1 6
GU 8 0 0 2 24 3 18
LEUK 249 3 157 16 195 36 219
LUNG 221 3 157 16 195 35 213
OTHER 14 1 52 4 49 6 37
PEOLC 64 0 0 0 0 4 24
PREV 230 3 157 10 122 21 128
SXQOL 485 5 261 41 499 94 572
Total 1424 20 1045 104 1267 224 1363

11-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 898 15 783 71 864 134 816
CCD 175 4 209 14 170 24 146
ERLYTX 55 0 0 2 24 6 37
GI 139 1 52 17 207 27 164
GU 327 2 104 35 426 69 420
LEUK 353 4 209 23 280 54 329
LUNG 379 4 209 31 377 67 408
LYMPH 285 7 365 25 304 47 286
MELAN 7 0 0 0 0 2 12
MMYEL 60 0 0 1 12 10 61
MULT 45 1 52 6 73 9 55
OTHER 141 1 52 5 61 10 61
PEOLC 66 0 0 0 0 1 6
PREV 230 3 157 10 122 21 128
SXQOL 485 5 261 41 499 94 572
Total 3645 47 2453 281 3419 575 3501

11-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 984 17 887 87 1059 163 992
ERLYTX 70 0 0 4 49 8 49
GI 97 0 0 8 97 11 67
GU 270 2 104 31 377 58 353
LEUK 137 4 209 12 146 25 152
LUNG 179 3 157 12 146 32 195
LYMPH 355 7 365 29 353 52 317
MMYEL 95 3 157 6 73 14 85
MULT 51 0 0 1 12 5 30
Total 2238 36 1879 190 2312 368 2240

11-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1907 28 1461 145 1765 293 1784
AFFIL 132 0 0 4 49 11 67
CCOP/NCORP 1210 15 783 92 1120 202 1230
Non-SWOG 1722 24 1252 154 1875 294 1790
Total 4971 67 3496 395 4809 800 4871

11-SEP-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
BREAST S2511 Brst, de novo StgIV oligo, locoreg tx vs SOC 1 Y 18-AUG-26
BREAST S2511 Brst, de novo StgIV oligo, locoreg tx vs SOC 2 Y 18-AUG-26
LYMPH S2506 NHL, R/R MZL, Mozun +/- Zanu or Pola 1 Y 18-AUG-26

11-SEP-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX SN2426 cSCC, IC Met/Inop, Amivantamab v Cetuximab 1 T 27-AUG-26
CCD S1703 Met Breast, STM-monitoring v Usual Care 1 N 15-AUG-26
LUNG A082002 Lung, Adv, Systemic Tx +/- SBRT 1 E 14-AUG-26

11-SEP-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 16
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 7
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 6
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 5
LUNG LUNGMAP NSCLC, Adv, Master 1 4
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 3
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 3
LYMPH S2114 NHL, Rel/Ref, CD19 CAR-T +/- Consolidation 1 3
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 3